Point72 Middle East FZE »

Cullinan Oncology shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 1.2k 10.19
2023-09-30 $64k 7.0k 9.05
2023-06-30 $59k 5.5k 10.76

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Cullinan Oncology

Blue Owl Capital Holdings
Franklin Resources
BVF
Vanguard Group
Braidwell
American International
Nextech Invest
Citadel Advisors
Dimensional Fund Advisors
Tang Capital Management
Deutsche Bank Aktiengesellschaft
OrbiMed Advisors
Charles Schwab Investment Management
Millennium Management
Hudson Bay Capital Management

View all funds holding Cullinan Oncology